These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 39218976)
1. Stanniocalcin 1 and 1,25-dihydroxyvitamin D Kim JH; Kim K; Kim I; Seong S; Koh JT; Kim N Exp Mol Med; 2024 Sep; 56(9):1991-2001. PubMed ID: 39218976 [TBL] [Abstract][Full Text] [Related]
2. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors. Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946 [TBL] [Abstract][Full Text] [Related]
3. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro. Yamaguchi M; Weitzmann MN Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202 [TBL] [Abstract][Full Text] [Related]
4. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo. Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399 [TBL] [Abstract][Full Text] [Related]
5. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320 [TBL] [Abstract][Full Text] [Related]
8. The vitamin D receptor in osteoblastic cells but not secreted parathyroid hormone is crucial for soft tissue calcification induced by the proresorptive activity of 1,25(OH) Nakamichi Y; Liu Z; Mori T; He Z; Yasuda H; Takahashi N; Udagawa N J Steroid Biochem Mol Biol; 2023 Sep; 232():106351. PubMed ID: 37352941 [TBL] [Abstract][Full Text] [Related]
9. 2α-Substituted Vitamin D Derivatives Effectively Enhance the Osteoblast Differentiation of Dedifferentiated Fat Cells. Ishizawa M; Takano M; Kittaka A; Matsumoto T; Makishima M Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927109 [TBL] [Abstract][Full Text] [Related]
10. Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro. Cong L; Zhang C; Tu G Int J Clin Exp Pathol; 2015; 8(5):5988-96. PubMed ID: 26191332 [TBL] [Abstract][Full Text] [Related]
11. Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation. Meyer MB; Benkusky NA; Lee CH; Pike JW J Biol Chem; 2014 Jul; 289(28):19539-54. PubMed ID: 24891508 [TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification. Fu B; Wang H; Wang J; Barouhas I; Liu W; Shuboy A; Bushinsky DA; Zhou D; Favus MJ PLoS One; 2013; 8(4):e61423. PubMed ID: 23620751 [TBL] [Abstract][Full Text] [Related]
14. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone. van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716 [TBL] [Abstract][Full Text] [Related]
15. Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts. Kim JH; Kim K; Youn BU; Lee J; Kim I; Shin HI; Akiyama H; Choi Y; Kim N J Cell Biol; 2014 Mar; 204(6):1063-74. PubMed ID: 24616223 [TBL] [Abstract][Full Text] [Related]
16. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts. Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510 [TBL] [Abstract][Full Text] [Related]
18. Mechanical loading and the synthesis of 1,25(OH)2D in primary human osteoblasts. van der Meijden K; Bakker AD; van Essen HW; Heijboer AC; Schulten EA; Lips P; Bravenboer N J Steroid Biochem Mol Biol; 2016 Feb; 156():32-9. PubMed ID: 26625962 [TBL] [Abstract][Full Text] [Related]
19. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice. Onal M; St John HC; Danielson AL; Pike JW J Bone Miner Res; 2016 Feb; 31(2):416-29. PubMed ID: 26332516 [TBL] [Abstract][Full Text] [Related]